327
The late 19 th and early 20 th centuries bore witness to a new era in respiratory physiology, as researchers turned their attention to the chemical control of breathing. In Oxford, John Scott Haldane and John Gillies Priestley correctly postulated that the regulation of alveolar ventilation depends principally on the partial pressure of carbon dioxide (CO 2 ) in the respiratory centre 1 . Other contemporaneous hypotheses, however, failed to stand the test of time. Conducting research in the high Italian Alps, as well as a low-pressure chamber, Angelo Mosso, Professor of Physiology in Turin, erroneously concluded that the effects of mountain sickness were due to a dramatic reduction in arterial CO 2 content, rather than hypoxia 2 . Mosso coined the term 'acapnia' to describe this condition. Soon after, the American physiologist Yandell Henderson proposed his flawed theory that acapnia (secondary to hyperventilationinduced by pain or the excitatory stages of ether anaesthesia) was the principal cause of cardiovascular and respiratory shock in surgical patients 3, 4 . Reasoning that vigorous artificial respiration might similarly render an individual dangerously acapnic 4 , Henderson began animal experiments to determine the value of administering inhaled CO 2 during resuscitation.
In 1909, Henderson outlined the 'strikingly successful results' 6 elicited when air or oxygen containing 5% or 6% CO 2 was A Sparklets resuscitator.
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The history of carbon dioxide in resuscitation administered to dogs undergoing artificial respiration. As soon as the tension of carbon dioxide rose in the animals' lungs, Henderson found that spontaneous breathing recommenced and was maintained as long as the inspired air contained sufficient carbon dioxide to stimulate the respiratory centre. Although Henderson had devised a simple gas meter for measuring the small quantities of CO 2 to be added to air or oxygen, he felt it would be better to have the gases premixed. He hoped to 'induce the manufacturers to supply tanks of oxygen containing 5% or 6% CO 2 [and] persuade clinicians to use it' 5 . Despite Henderson's enthusiasm, physicians largely ignored the physiologist's suggestion; it would be more than a decade before inhaled carbon dioxide found a clinical application.
In March 1920, Henderson and co-worker Howard Haggard outlined the therapeutic use of carbon dioxide to speed up excretion of volatile anaesthetic agents after prolonged anaesthesia 6 . Later that year, using dogs asphyxiated with city illuminating gas, they demonstrated that the administration of 10% CO 2 in oxygen resulted in faster elimination of carbon monoxide than oxygen alone 7 . Carbon monoxide poisoning was a very real problem during this era, and Henderson and Haggard 'hoped to carry this matter into practical application' 7 . At a meeting of the Commission on Resuscitation from Carbon Monoxide Asphyxia held in November 1921, they were instructed to conduct further investigations on the treatment of carbon monoxide poisoning using the inhalation of CO 2 8 . In their laboratory, Henderson and Haggard determined that the inhalation of 5% CO 2 in oxygen was both tolerable and beneficial for humans who had been exposed to high levels of carbon monoxide 8 . This gas mixture was named Carbogen and supplied to the researchers in prefilled cylinders by the Union Carbide and Carbon Company, and the Linde Air Products Company. In conjunction with the US Mines Safety Appliances Company, Henderson and Haggard developed a new piece of apparatus for the delivery of Carbogen. Known as the H-H inhaler, this comprised a pressure-reducing valve and graduated needle valve upstream of a 4 or 5 litre reservoir bag, which was in turn connected to a facemask by rubber tubing. An expiratory valve on the mask prevented rebreathing of exhaled gases. This equipment was subsequently field-tested in the New York Borough of Manhattan, where Henderson and Haggard enlisted the help of the Consolidated Gas Company's emergency crews. These individuals already had extensive experience dealing with victims of carbon monoxide poisoning and were trained in manual artificial respiration. The crews dealt with a total of 80 cases of carbon monoxide poisoning during the two-month study period. Carbogen was tried in 12 victims. Although concomitant artificial respiration
The history of carbon dioxide in resuscitation was sometimes necessary, it was reported to stimulate ventilation and speed up the elimination of carbon monoxide in most of these cases.
By 1924 further data supporting the use of inhaled CO 2 in severe carbon monoxide poisoning had emerged from the USA and parts of Europe 9 . Bolstered by these findings, Henderson urged that every hospital ambulance and fire engine should carry a Carbogen inhaler 9 , suggesting that the therapy might also be of benefit for other types of respiratory failure, including opioid toxicity and pneumonia.
As the use of Carbogen increased, so did the range of devices available for its delivery. These included the 'Edina' and 'Carbetha' apparatus, produced by Siebe Gorman and Co 10 . However, some individuals found Carbogen cylinders impractical, since the increased pulmonary ventilation induced by the gas meant that even the largest cylinders were rapidly depleted 10 .
It was found that similar results could be obtained by administering a stream of pure CO 2 alongside oxygen or air. In 1927, Whitridge Davies from the Department of Physiology, University of Leeds, described the Sparklets Resuscitator, a new, simple apparatus for this purpose 10 . Developed with the assistance of the University of Edinburgh Department of Mining and the London soda syphon manufacturer, Sparklets Ltd, this consisted of a disposable metal bulb containing liquid CO 2 and a holder. When required, a bulb was screwed into the holder. This punctured the outer casing and allowed 100% CO 2 to escape through a gas outlet, under the control of a regulating needle valve. The maximum flow rate was approximately 2 litres per minute and the CO 2 was delivered to the patient via a rubber tube, attached to the gas outlet. The distal end of the tubing could be placed underneath an ordinary Schimmelbusch mask, attached to a glass funnel, or inserted into the patient's nasopharynx. Although two sizes of Sparklet bulb were later manufactured, only J size bulbs were initially available. These contained 25 grams of liquid CO 2 , and would produce approximately 12 litres of gas. J size bulbs were 6¼ inches in length and slightly more than ¾ inch in diameter. Attached to the holder, the whole apparatus measured 10 inches in length and at its maximum, 3¼ inches in width. Together with half a dozen Sparklet bulbs, the entire resuscitator therefore took up little space inside a doctor's bag 10 .
While CO 2 was subsequently recommended in first aid manuals 11, 12 and used for neonatal resuscitation 13 , whooping cough 14 , asthma 15, 16 , chronic rhinitis 16 , and even hiccoughs 16 , sceptics began to question the wisdom of Henderson's acapnia theory and the safety of Carbogen from 1945 onwards [17] [18] [19] [20] [21] [22] . Although the technique continued to have its supporters 23 , this largely heralded the beginning of the end for CO 2 in resuscitation.
